Literature DB >> 34343623

Preoperative Quadratus Lumborum Block Reduces Opioid Requirements in the Immediate Postoperative Period Following Hip Arthroscopy: A Randomized, Blinded Clinical Trial.

Sylvia H Wilson1, Renuka M George2, Jennifer R Matos2, Dulaney A Wilson3, Walter J Johnson4, Shane K Woolf5.   

Abstract

PURPOSE: To examine acute postoperative opioid consumption in patients undergoing hip arthroscopy and randomized to either receive a preoperative lateral quadratus lumborum block or sham injection.
METHODS: This trial randomized 46 subjects undergoing hip arthroscopy with a single surgeon to receive a preoperative lateral quadratus lumborum block (40 mL, ropivacaine 0.25%) or sham injection. The primary outcome was postoperative opioid consumption in patients with and without a block. All opioid medications were converted to morphine milligram equivalents for comparisons. Categorical data were compared with χ2 tests and Fisher exact tests where appropriate. Continuous data were compared with 2-sided t-test and Wilcoxon rank-sum tests.
RESULTS: Forty-six subjects scheduled for elective hip arthroscopy were successfully consented and randomized. Demographic and clinical characteristics did not differ. Postoperative opioid consumption decreased 28.3% in patients who received a preoperative lateral quadratus lumborum block (P = .04). Total perioperative opioid consumption (intraoperative and postoperative combined) was reduced 20% in the block group; however, this did not achieve statistical significance (P = .05). Three subjects in the sham group (12.5%) required unblinding for a rescue block in the postoperative anesthetic care unit (PACU) for uncontrolled pain despite systemic analgesics. While cold sensation was decreased postoperatively over the abdomen (P < .001) and anterior thigh (P = .03) in the block group, other PACU variables did not differ, including VAS pain scores, motor function, side effects, PACU duration, and patient satisfaction.
CONCLUSIONS: Opioid consumption was reduced in patients who received a preoperative lateral quadratus lumborum block combined with a standardized, multimodal protocol as compared with patients who did not receive a block. Our findings support the growing evidence that quadratus lumborum blocks are an effective component of multimodal analgesia options for patients undergoing elective hip arthroscopy. LEVEL OF EVIDENCE: Level I, randomized controlled trial.
Copyright © 2021 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34343623      PMCID: PMC8801544          DOI: 10.1016/j.arthro.2021.07.029

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   5.973


  33 in total

1.  Perioperative Opioid Analgesics and Hip Arthroscopy: Trends, Risk Factors for Prolonged Use, and Complications.

Authors:  Victor Anciano Granadillo; Jourdan M Cancienne; F Winston Gwathmey; Brian C Werner
Journal:  Arthroscopy       Date:  2018-05-03       Impact factor: 4.772

Review 2.  Chronification of Pain: Mechanisms, Current Understanding, and Clinical Implications.

Authors:  Daniel J Pak; R Jason Yong; Alan David Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

3.  Extravasated Fluid in Hip Arthroscopy and Pain: Is Quadratus Lumborum Block the Answer?

Authors:  Bruce Ben-David; Luca La Colla
Journal:  Anesth Analg       Date:  2017-07       Impact factor: 5.108

4.  Quadratus Lumborum Block as an Alternative to Lumbar Plexus Block for Hip Surgery: A Report of 2 Cases.

Authors:  Luca La Colla; Bruce Ben-David; Rita Merman
Journal:  A A Case Rep       Date:  2017-01-01

5.  A Retrospective Study Evaluating the Effect of Low Doses of Perineural Dexamethasone on Ropivacaine Brachial Plexus Peripheral Nerve Block Analgesic Duration.

Authors:  Gregory D Schnepper; Benjamin I Kightlinger; Yunyun Jiang; Bethany J Wolf; Eric D Bolin; Sylvia H Wilson
Journal:  Pain Med       Date:  2018-07-01       Impact factor: 3.750

Review 6.  Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.

Authors:  Alan D Kaye; Mark R Jones; Adam M Kaye; Juan G Ripoll; Vincent Galan; Burton D Beakley; Frank Calixto; Jamie L Bolden; Richard D Urman; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2017-02       Impact factor: 4.965

7.  Pain Management After Hip Arthroscopy: Systematic Review of Randomized Controlled Trials and Cohort Studies.

Authors:  Jason J Shin; Chris L McCrum; Craig S Mauro; Dharmesh Vyas
Journal:  Am J Sports Med       Date:  2017-10-13       Impact factor: 6.202

8.  Continuous Quadratus Lumborum Block for Postoperative Pain in Total Hip Arthroplasty: A Case Report.

Authors:  Margaret M Hockett; Sheena Hembrador; Alex Lee
Journal:  A A Case Rep       Date:  2016-09-15

9.  Postoperative analgesia and opioid use following hip arthroscopy with ultrasound-guided quadratus lumborum block: a randomized controlled double-blind trial.

Authors:  Liangjing Yuan; Ye Zhang; Chengshi Xu; Anshi Wu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

10.  Transmuscular quadratus lumborum block versus thoracic paravertebral block for acute pain and quality of recovery after laparoscopic renal surgery: study protocol for a randomized controlled trial.

Authors:  Qing Yuan; Xulei Cui; Yuda Fei; Zhonghuang Xu; Yuguang Huang
Journal:  Trials       Date:  2019-05-20       Impact factor: 2.279

View more
  2 in total

Review 1.  Postoperative analgesic effectiveness of quadratus lumborum block: systematic review and meta-analysis for adult patients undergoing hip surgery.

Authors:  Haolan Xiong; Xiaohua Chen; Wenxiu Zhu; Wuke Yang; Fuming Wang
Journal:  J Orthop Surg Res       Date:  2022-05-19       Impact factor: 2.677

2.  Efficacy of Quadratus Lumborum Block for Pain Control in Patients Undergoing Hip Surgeries: A Systematic Review and Meta-Analysis.

Authors:  Jinfeng Li; Chenpu Wei; Jiangfa Huang; Yuguo Li; Hongliang Liu; Jun Liu; Chunhua Jin
Journal:  Front Med (Lausanne)       Date:  2022-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.